Lanx draws $8.7M for spinal fusion device development

Lanx, a Colorado maker of spinal fusion devices, has pulled in $8.7 million in new funding. Chief Financial Officer Steve Deitsch told MedCity News that the money will be used, in part, to boost marketing of its Timberline lateral fusion system, which debuted in February. Funding will also support bringing as many as 6 new products to market in 2016. The funding round isn't complete, however. According to the story, Lanx wants to raise $15.1 million overall. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.